Notable
Progerinin in Werner Syndrome
Primary endpoint(s) modified
Also in this update: Recruitment opened
PRG Science & Technology Co., Ltd.Phase 2 NCT05847179 Registry history of NCT05847179 on ClinicalTrials.gov (opens the registry)
Updated
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
Primary endpoint(s) modified
Also in this update: Recruitment opened
PRG Science & Technology Co., Ltd.Phase 2 NCT05847179 Registry history of NCT05847179 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Study completion date changed from estimate of Mar 2026 to Apr 30, 2026
PRG Science & Technology Co., Ltd.Phase 2 NCT06775041 Registry history of NCT06775041 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT05847179 | Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner… | Werner Syndrome | Recruiting | 2026-10-05 |
| Phase 1/2 | ||||
| NCT07131722 | Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients… | Neurofibromatosis Type II | Not Yet Recruiting | 2026-01-23 |
| Phase 1 | ||||
| NCT07221240 | Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult… | Amyotrophic Lateral Sclerosis | Recruiting | 2026-03-05 |
ALS (1)